Cornea/External Disease News

CHICAGO — In this Healio Video Perspective from the AAO meeting, Ranjan P. Malhotra, MD, FACS, discusses how Vevye, a higher-concentration formulation of cyclosporine, is “changing the landscape” in dry eye.

The earlier we detect keratoconus, the better our chances of preserving functional vision by stabilizing the cornea with cross-linking treatment.

Cross-linking is a unique procedure. As cornea surgeons, we depend on referring doctors to screen for keratoconus, a relatively rare disease.

CHICAGO — In this Healio Video Perspective from the AAO meeting, Matthew Giegengack, MD, of Wake Forest University discusses the outcomes of corneal endothelial cell therapy for endothelial dysfunction.

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Nordic Pharma Eye Care U.S. president Philip Gioia and chief commercial officer Jai G. Parekh, MD, MBA, FAAO, discuss Lacrifill’s launch and its impact on dry eye treatment.

CHICAGO — In this Healio Video Perspective from the AAO meeting, Jennifer M. Loh, MD, shares results from the NEAR phase 3 clinical trials, which investigated Qlosi, a low-dose pilocarpine eye drop for the treatment of presbyopia.

Bausch + Lomb has announced that its Soothe antibiotic drops have been approved by Health Canada for over-the-counter use in the treatment of external infections of the eye and ear, according to a company press release.

CHICAGO — Many diseases can present as dry eye, leading to missed diagnoses and failed treatment, according to a speaker here.

CHICAGO — In this Healio Video Perspective from the AAO meeting, William B. Trattler, MD, discusses a study that evaluated age and keratoconus progression.

Okyo Pharma has announced that screening and recruitment has been initiated for a phase 2 trial of OK-101 to treat neuropathic corneal pain, with plans to enroll 48 patients, according to a company press release.